These cryopreserved human female hepatocytes are suitable for use in suspension metabolism applications.
Cells per vial: 4–8 million
The commonly tested Phase I (P450) and Phase II (UGT, SULT) drug metabolizing enzymes were analyzed for metabolic activity in each lot. Metabolite formation was measured by standard biochemical assays using LC/MS/MS or HPLC.
Get the Results You Need with GIBCO Hepatocytes High quality hepatocytes, with high viabilities, in vivo-like enzyme expression levels, and proper cell morphology increase the ability to draw in vitro⁄in vivo correlations and make sound decisions regarding a compound's fate. Experienced technicians and proprietary isolation techniques combined with stringent release specifications ensure you receive the highest quality cryopreserved hepatocytes.
Each lot is tested for: • Phase I and II enzyme activities • Proper morphology • Viabilities generally >75%
For research use only. Not intended for human or animal therapeutic or diagnostic use.